Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 8,633,348
- Share change
- +3,960,204
- Total reported value
- $18,127,749
- Price per share
- $2.10
- Number of holders
- 27
- Value change
- +$8,211,749
- Number of buys
- 14
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
13%
|
3,596,680
|
$16,725,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
356,881
|
$1,659,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.73%
|
207,173
|
$964,000 | — | 31 Dec 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.53%
|
150,000
|
$698,000 | — | 31 Dec 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
145,000
|
$674,000 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
44,048
|
$205,000 | — | 31 Dec 2017 | |
| Destination Wealth Management |
13F
|
Company |
0.1%
|
29,656
|
$138,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
22,179
|
$103,000 | — | 31 Dec 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
16,783
|
$78,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
16,041
|
$75,000 | — | 31 Dec 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
15,899
|
$73,000 | — | 31 Dec 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.06%
|
15,700
|
$73,000 | — | 31 Dec 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
10,386
|
$48,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
8,465
|
$39,000 | — | 31 Dec 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.03%
|
7,393
|
$34,000 | — | 31 Dec 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
6,400
|
$30,000 | — | 31 Dec 2017 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
5,187
|
$24,000 | — | 31 Dec 2017 | |
| STRS OHIO |
13F
|
Company |
0.02%
|
4,600
|
$21,000 | — | 31 Dec 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.01%
|
4,250
|
$20,000 | — | 31 Dec 2017 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
2,588
|
$12,000 | — | 31 Dec 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
1,946
|
$9,000 | — | 31 Dec 2017 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0%
|
1,400
|
$7,000 | — | 31 Dec 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,050
|
$5,000 | — | 31 Dec 2017 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
746
|
$3,469 | — | 31 Dec 2017 | |
| Carroll Financial Associates, Inc. |
13F
|
Company |
0%
|
850
|
$3,000 | — | 31 Dec 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
700
|
$3,000 | — | 31 Dec 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
675
|
$3,000 | — | 31 Dec 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
609
|
$3,000 | — | 31 Dec 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
596
|
$3,000 | — | 31 Dec 2017 | |
| Parallax Volatility Advisers, L.P. |
13F
|
Company |
0%
|
546
|
$3,000 | — | 31 Dec 2017 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0%
|
563
|
$2,000 | — | 31 Dec 2017 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
500
|
$2,000 | — | 31 Dec 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
384
|
$2,000 | — | 31 Dec 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
339
|
$2,000 | — | 31 Dec 2017 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
316
|
$1,000 | — | 31 Dec 2017 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
112
|
$1,000 | — | 31 Dec 2017 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q1 2018
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.